Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors

Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors

US Patent 11773150 · Granted Oct 3, 2023

Estimated economic value: $303,606,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phthalocyanine dye conjugate compositions2025
PCSK9 antagonist compounds2025
Anti-TIGIT antibodies2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Anti-TIGIT antibodies2024
Cyclic polypeptides for PCSK9 inhibition2024
Phosphonate linkers and their use to facilitate cellular retention of compounds2024
Modified relaxin polypeptides and their uses2023
Modified lipidated relaxin B chain peptides and their therapeutic use2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2023